Chief Legal Officer of $MNMD sells 11,278 shares in insider sale

The recent sale of shares by Mark Sullivan, the Chief Legal Officer of $MNMD, has caught the attention of investors and analysts alike. Sullivan offloaded 11,278 shares of the company on 09-25-2025, totaling an estimated $110,186. This transaction, disclosed in a recent SEC filing, represented around 3.7% of his holdings in this particular class of $MNMD stock.

Recent data shows that $MNMD insiders have been active in trading the company’s stock over the past six months, with 0 purchases and 6 sales recorded. Among the key insider moves, Robert Barrow, the Chief Executive Officer, has sold 52,288 shares for about $432,175. Meanwhile, Daniel Karlin, the Chief Medical Officer, has divested 15,552 shares, amounting to roughly $128,634.

The hedge fund activity surrounding $MNMD has seen significant action in the financial markets. Notably, 71 institutional investors have increased their stakes in $MNMD, while 96 have decreased their positions in the most recent quarter. Some of the largest moves in this sector include Octagon Capital Advisors LP removing 16,220,000 shares from their holdings, Marshall Wace, LLP adding 828,067 shares, and Tri Locum Partners LP selling off all 820,793 shares in Q1 2025.

On the analyst front, Wall Street firms have been closely monitoring $MNMD, with one firm issuing a “Buy” rating recently. Chardan Capital, on 08/01/2025, released a positive outlook on the stock. Meanwhile, multiple analysts have set price targets for $MNMD, with a median target of $22.5. Jay Olson from Oppenheimer has set a target price of $25.0, and Rudy Li from Chardan Capital has a target of $20.0, both as of early August 2025.

It’s essential for investors and market participants to stay updated on insider trading activities, hedge fund movements, analyst ratings, and price targets to make informed decisions about their investments. As with all financial news and analysis, it’s crucial to conduct further research and due diligence before making any investment decisions based on this information. For more detailed insights and tracking tools, interested parties can refer to Quiver Quantitative’s platforms for comprehensive data and market analysis.